Abiopharma

🔍 Myers Timothy D (Executive)

Company: Bank of Marin Bancorp (BMRC)

Report Date: 2024-04-01

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2024-04-01 | Code: H | shares_owned_after: 124,173.33
• Holds 0 shares of Common Stock (Direct)
  Date: 2024-04-01 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 14,786.19
• Holds 1,300 shares of Stock Options (Right to Buy) at $22.94 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2024-04-01 | Exercise: 2019-04-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 2,980 shares of Stock Options (Right to Buy) at $25.38 per share (Derivative)
  Date: 2025-03-02 | Code: H | Expires: 2025-03-02 | Exercise: 2018-03-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4
• Holds 5,380 shares of Stock Options (Right to Buy) at $24.83 per share (Derivative)
  Date: 2026-03-01 | Code: H | Expires: 2026-03-01 | Exercise: 2019-03-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5, F4
• Holds 3,720 shares of Stock Options (Right to Buy) at $34.8 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2027-03-01 | shares_owned_after: 3,720.00 | Footnotes: F4
• Holds 2,000 shares of Stock Options (Right to Buy) at $33.58 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2028-03-01 | shares_owned_after: 2,000.00 | Footnotes: F6
• Holds 4,140 shares of Stock Options (Right to Buy) at $33.58 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2028-03-01 | shares_owned_after: 4,140.00 | Footnotes: F4
• Holds 3,600 shares of Stock Options (Right to Buy) at $44.45 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2029-03-01 | shares_owned_after: 3,600.00 | Footnotes: F4
• Holds 2,670 shares of Stock Options (Right to Buy) at $40.1 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2030-03-02 | shares_owned_after: 2,670.00 | Footnotes: F4
• Holds 2,099 shares of Stock Options (Right to Buy) at $38.25 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2031-03-01 | shares_owned_after: 2,099.00 | Footnotes: F4
• Holds 3,616 shares of Stock Options (Right to Buy) at $38.11 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2031-10-29 | Exercise: 2021-10-29 | shares_owned_after: 3,616.00
• Holds 4,629 shares of Stock Options (Right to Buy) at $34.03 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2032-03-01 | shares_owned_after: 4,629.00 | Footnotes: F4

Footnotes:

• F1: The stock option was granted on April 1, 2014 and vested in equal annual installments over five years, becoming fully exercisable on April 1, 2019. The option expired unexercised on April 1, 2024. This Form 4 is being filed late due to an administrative oversight.
• F2: Exercisable 20% per year beginning on first anniversary date of grant.
• F3: The stock option was granted on March 2, 2015 and vested in equal annual installments over three years, becoming fully exercisable on March 2, 2018. The option expired unexercised on March 2, 2025. This Form 4 is being filed late due to an administrative oversight.
• F4: Exercisable 33% per year beginning on first anniversary date of grant.
• F5: The stock option was granted on March 1, 2016 and vested in equal annual installments over three years, becoming fully exercisable on March 1, 2019. The option expired unexercised on March 1, 2026. This Form 4 is being filed late due to an administrative oversight.
• F6: Exercisable 33% per year beginning on first anniversary date of grant.